Signet Therapeutics empowers targeted cancer drug discovery and development using novel disease models.
Haisheng Zhang
Founder and CEO
Signet
Close
Healthcare
Targeted cancer drugs and cell-based organoid development
Favorite Innovator
Reinhold Niebuhr